Form 4: Arteris Insider Sells Shares Under 10b5-1 Plan

Bayview Legacy, LLC, controlled by K. Charles Janac, reported the sale of 70,000 shares of Arteris, Inc. common stock for approximately $19.04 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Bayview Legacy, LLC, managed by K. Charles Janac, sold 70,000 shares of Arteris, Inc. common stock.
• The transaction occurred on April 8, 2026, with a weighted average sale price of $19.0398 per share.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on March 5, 2025.
• Following the transaction, Bayview Legacy, LLC beneficially owns 9,119,071 shares of Arteris, Inc. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it reports a significant sale of shares by an insider, the transaction was conducted under a pre-established 10b5-1 plan, mitigating concerns about opportunistic trading.

Negatives

• Insider selling of a significant number of shares, although executed under a pre-planned trading strategy.

Risks

• The filing does not explicitly detail risks, but insider selling can sometimes be perceived negatively by the market.

Future Outlook

The filing itself does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports a past transaction.

Management Comments

• K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as his manager.
• Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.
• The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.67 to $19.43 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from Arteris, Inc., are standard disclosures for insider transactions. The execution of a 10b5-1 plan is a common strategy for insiders to diversify holdings or manage liquidity without creating the appearance of trading on material non-public information. The specific details of the sale price range and the number of shares sold provide transparency to the market regarding insider activity.

Stakeholder Impact

• Shareholders: The sale of shares by a significant beneficial owner, even under a 10b5-1 plan, may lead to short-term market perception shifts. However, the pre-planned nature of the sale aims to reduce adverse impact.
• Management: K. Charles Janac, as manager of Bayview Legacy, LLC, is demonstrating a planned divestment strategy.

Key Dates

Keywords

Arteris Inc, AIP, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Beneficial Ownership, Bayview Legacy LLC, K. Charles Janac